Skip to main content

Nonprofit · EIN 54-1660976

MYOSITIS ASSOCIATION

Tax-exempt · COLUMBIA, MD 21046

Financials

$1.2M$1.9M2023$2M$1.8M2024
Revenue Expenses · by fiscal year end
Financials of MYOSITIS ASSOCIATION by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$2,012,099$1,794,414$217,685$2,013,453$469,479$1,543,974
December 31, 2023990$1,249,899$1,888,477-$638,578$1,779,524$489,420$1,290,104
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$1,576,936
Program service revenue
$434,403
Investment income
$32,159
Net gain from sales of assets
$1,503
Net income from sales of inventory
-$30,945
Other revenue
-$31,399

Expenses

Grants and similar amounts paid
$331,216
Compensation of officers, directors and key employees
$192,132
Other salaries and wages
$200,115
Salaries, compensation and benefits (total)
$451,199
Professional fundraising fees
$0
Legal fees
$15,804
Accounting fees
$87,793
Occupancy
$89,036
Travel
$34,893
Depreciation
$7,081
Program services (functional)
$1,258,554
Management and general (functional)
$368,551
Fundraising (functional)
$167,309

Balance sheet and other

Total assets, start of year
$1,779,524
Total assets, end of year
$2,013,453
Total liabilities, end of year
$469,479
Net assets, end of year
$1,543,974
Land, buildings and equipment
$43,512
Publicly traded securities
$1,116,945
Net assets without donor restrictions
$1,151,091
Net assets with donor restrictions
$392,883
Gross unrelated business income
$1,000
Gross receipts
$2,380,615
Employees
4
Volunteers
92
Year formed
1993
State of legal domicile
VA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensation
Paula EichenbrennerExecutive Dir.
Officer
40$180,562
Laurie Boyer ChairDirector
Trustee or director, Officer
3$0
Rich DeAugustinis Vice ChairDirector
Trustee or director, Officer
1.5$0
Martha Arnold SecretaryDirector
Trustee or director, Officer
1.5$0
Howard Gerrin TreasurerDirector
Trustee or director, Officer
1.5$0
Jeff AutreyDirector
Trustee or director
0.5$0
Iazsmin Bauer VenturaDirector
Trustee or director
0.5$0
Richard Chip GallowayDirector
Trustee or director
0.5$0
Holly JonesDirector
Trustee or director
0.5$0
Frank LipieckiDirector
Trustee or director
0.5$0
Ricky MarksDirector
Trustee or director
0.5$0
David MochelDirector
Trustee or director
1.5$0
Tahseen MozaffarDirector
Trustee or director
0.5$0
Jane MylesDirector
Trustee or director
0.5$0
Rodger OrenDirector
Trustee or director
0.5$0
3 more people on this return
NameTitleHours / weekCompensation
Meriel ParkerDirector
Trustee or director
0.5$0
Mustafa ShameemDirector
Trustee or director
0.5$0
Nita SharmaDirector
Trustee or director
0.5$0
990 for the year ended December 31, 2023: 20 people
NameTitleHours / weekCompensation
Rhonda Buckley-Bishop InterimExecutive Dir.
Officer
40$183,137
Chris Thornton OutgoingExecutive Dir.
Officer
40$20,436
Paula Eichenbrenner IncomingExecutive Dir.
Officer
40$16,231
Martha ArnoldSecretary
Trustee or director, Officer
1.5$0
Laurie Boyer Vice ChairDirector
Trustee or director, Officer
1.5$0
Jeff AutreyDirector
Trustee or director
0.5$0
Gail BaylissDirector
Trustee or director
0.5$0
Rex BickersDirector
Trustee or director
0.5$0
David Mochel ChairDirector
Trustee or director, Officer
1.5$0
Marianne MoyerDirector
Trustee or director
0.5$0
Ronne AdkinsDirector
Trustee or director
0.5$0
Rodger OrenDirector
Trustee or director
0.5$0
Iazsmin Bauer VenturaDirector
Trustee or director
0.5$0
Holly JonesDirector
Trustee or director
0.5$0
Frank LipieckiDirector
Trustee or director
0.5$0
Rich DeAugustinisTreasurer
Trustee or director, Officer
1.5$0
Ricky MarksDirector
Trustee or director
0.5$0
Nita SharmaDirector
Trustee or director
0.5$0
Howard GerrinDirector
Trustee or director
0.5$0
Tahseen MozaffarDirector
Trustee or director
0.5$0

Address and contacts

Address (IRS master file)
6950 COLUMBIA GATEWAY DR STE 370, COLUMBIA, MD 21046-3492
Principal officer (990 for 2024)
Laurie Boyer
Signed the 990
Paula Eichenbrenner, Executive Director
Phone
(800) 821-7356
Return prepared by
Quist & Associates LLC

Mission

The mission of The Myositis Association, or TMA, is: to improve the lives of persons affected by myositis, fund innovative research, and increase myositis awareness and advocacy. TMA is the premier international organization providing important resources, education and support to those in the myositis community. This community consists of children, adults, and their families who live with the daunting and life-changing physical, psychological and emotional effects of myositis. Nationwide, an estimated 75,000 Americans are affected by this collection of rare diseases. Symptoms of myositis include, but are not limited to: muscle weakness pain fatigue tripping or falling trouble swallowing difficulty breathing and irritations of the skin, joints, and eyes. Myositis is often difficult to diagnose, because many physicians are unfamiliar with the disease and its symptoms. Also, as a rare disease, it can be difficult to enroll enough patients to conduct adequate research of new treatments, an

990 for the year ended December 31, 2024

Program accomplishments

  • Global Myositis Patient Conference: TMA has convened myositis patients, care partners, and clinicians for a multi-day conference focused on learning and community-building since 1995. TMA's International Annual Patient Conference (IAPC) is now an annual event with panels of medical experts, peer counseling, sessions on coping skills, exercise workshops, and time to meet other patients and their families. The 2024 IAPC took place in Baltimore, Maryland, US, from Sept. 4-7. The conference included our first off-site medical and sightseeing excursions; TMA's Heroes in the Fight Awards; and a virtual recordings package to extend the reach of our conference breakout sessions. Many of TMA's members cannot travel, due to the progressively debilitating nature of their form of myositis. TMA offers the conference recordings at a discounted price to share the learnings from TMA's IAPC as widely and inclusively as possible.
    Expenses $527,150 · grants $15,084 · revenue $433,403
  • Research Grants: TMA aims to identify the underlying causes and natural progression of myositis, develop better treatments and more effective therapies, and ultimately to arrive at cures for this collection of disabling diseases. Through our research program, we progress toward a world without myositis. Twelve TMA grants were active in 2024. We continued our research fellowship program to attract and encourage post-doctoral trainees (PhD and MD) and early-career physicians to pursue careers in the field of myositis research, and funded innovative pilot projects. From 2002 to 2024, TMA has awarded 68 research grants totaling nearly $8 million. Two new projects were approved in 2024: "Senolytic therapies in a novel patient-derived myoblast model of inclusion body myositis and Mitochondrial contribution to juvenile dermatomyositis." The grants portfolio is designed to advance our collective understanding of inclusion body myositis, dermatomyositis, necrotizing myopathy, polymyositis, and all forms of myositis. Scientists, practicing physicians, and other medical professionals have supported TMA through our active Medical Advisory Board. This group provides medical information to staff and patients, and guides the TMA research program.
    Expenses $407,313 · grants $316,132
  • Other Program Services: TMA's other initiatives are focused on awareness, advocacy, and clinician outreach. We are continually updating approximately 13,000 members through monthly e-newsletters, quarterly magazines, videos on YouTube, social media channels, and the highly trafficked website myositis.org. Our efforts to elevate the understanding of myositis among the general public are very important. Because these diseases are very rare, advocacy on behalf of the families affected by myositis is a core component of our mission. In 2024, we organized Myositis Awareness Month from May 1-31, 2024 and we participated in World Myositis Day on September 21, 2024. TMA also provides resources for healthcare professionals, to ensure that they receive the latest information on treating myositis and communicating effectively with their patients. We publish various resources, including our "Myositis 101" physician booklets, disease overview brochures, and infographics. In 2024, we hosted a myositis research symposium for physicians and experts during our Global Myositis Patient Conference; we co-hosted an Externally-Led Patient-Focused Drug Development meeting with regulatory decision-makers and MSU; and we co-hosted a summit featuring "Recent Advances in Myositis Research and Treatment" with the Cure Juvenile Myositis (JM) Foundation.
    Expenses $186,301
  • Patient Support and Education: TMA's Support Groups offer members the chance to share their feelings and discuss their concerns with people in similar situations. These groups, which are offered in-person and virtually, encourage an atmosphere of communication and compassion. TMA also administers Affinity Groups with outreach targeted toward supporting and extending our organization's reach into new communities. Through Affinity Groups, TMA brings together of people who have commonality such as Military Veterans, Women with IBM, Women of Color, Care Partners, and more. TMA's 36 regional Support Groups and 8 virtual Affinity Groups welcomed nearly 4,000 patients and care partners to group meetings in 2024. TMA's educational efforts, especially those organized during Myositis Awareness Month and World Myositis Day, create broader community awareness, direct our members to TMA offerings and resources, educate around patient and disease advocacy, share clinical insights, and build a stronger and more connected myositis community. TMA resources share information on diagnosis, treatments, research news, and other relevant topics that help patients and care partners learn what they need to address their individual health care concerns. TMA additionally hosts webinars year-round, including our monthly Ask the Expert series as well as Research Insights, Empowerment Clinic, and Awareness Clinic offerings. 1,399 registrants participated in TMA's virtual programs in 2024.
    Expenses $137,790

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
54-1660976
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
1993
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Human services (P82Z)
Assets (IRS master file)
$2,013,453
Income (IRS master file)
$2,380,615

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$2,012,099$1,794,414$2,013,453XML
990-TDecember 2024–––IRS
990December 2023$1,249,899$1,888,477$1,779,524XML
990-TDecember 2023–––IRS
990December 2022$1,317,262$1,654,469$2,327,942IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 54-1660976).

Questions about MYOSITIS ASSOCIATION

What is the EIN of MYOSITIS ASSOCIATION?
The employer identification number (EIN) of MYOSITIS ASSOCIATION is 54-1660976.
Is MYOSITIS ASSOCIATION tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1993.
Are donations to MYOSITIS ASSOCIATION tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does MYOSITIS ASSOCIATION file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of MYOSITIS ASSOCIATION due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did MYOSITIS ASSOCIATION last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of MYOSITIS ASSOCIATION?
The 990 for the year ended December 31, 2024 names Laurie Boyer.
Who are the officers and directors of MYOSITIS ASSOCIATION?
The 990 for the year ended December 31, 2024 lists 18 people; 1 received compensation from the organization, the highest $180,562 (Paula Eichenbrenner, Executive Dir.).
How much revenue does MYOSITIS ASSOCIATION have?
On its 990 for the year ended December 31, 2024 it reported revenue of $2,012,099, expenses of $1,794,414 and total assets of $2,013,453 at year end.

Other nonprofits in COLUMBIA

All nonprofits in COLUMBIA · Maryland · Human services